Physician

Steven Jeffrey Hager, D.O.

According to 2025 Medicare claims, Steven Hager, D.O. (NPI: 1326087917) practices hematology/oncology in the Fresno, CA market, with the plurality of this provider's patient population coming from Fresno, CA. This provider's primary affiliated billing organization is CALIFORNIA CANCER ASSOCIATES FOR RESEARCH AND EXCELLENCE INC (NPI: 1083661607; TIN: 770324589) and primary practice location at 93720-3347.

Hager's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 941 traditional Medicare patients, billed 315,861 HCPCS/CPT codes, and received $5,165,204 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,900 prescription claims across 375 beneficiaries totaling $7,576,445 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 129 claims. Open Payments data shows 124 records totaling $36,287. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,824,051 to $5,165,204. Similarly, Part D prescription costs have moved sharply higher in recent years, from $970,193 to $7,576,445. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,356 and ending at $2,469.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	932	236,500	$1,824,051
2016	922	272,784	$2,370,024
2017	920	270,678	$2,719,094
2018	951	324,081	$3,078,998
2019	703	269,252	$2,745,720
2020	947	304,968	$3,970,747
2021	998	307,341	$4,532,396
2022	1,071	366,565	$4,532,522
2023	1,219	402,216	$6,914,712
2024	941	315,861	$5,165,204

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	227	1,412	$970,193
2016	225	1,576	$1,860,161
2017	232	1,784	$2,310,019
2018	262	1,881	$2,727,844
2019	229	1,694	$3,215,327
2020	239	1,847	$4,037,392
2021	269	2,053	$4,639,719
2022	302	2,189	$5,838,874
2023	368	2,785	$6,754,703
2024	375	2,900	$7,576,445

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	12	137	$52,862
2016	23	106	$30,160
2017	12	59	$14,514
2018	N/R	72	$9,205
2019	N/R	78	$5,510
2020	N/R	13	$1,623
2021	17	22	$3,038
2022	N/R	24	$2,525
2023	14	108	$17,177
2024	12	129	$6,150

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	372	1,018	$96
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	355	532	$64
80053	Blood test, comprehensive group of blood chemicals	441	1,257	$10
36415	Insertion of needle into vein for collection of blood sample	514	1,964	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	507	2,044	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	62	1,736	$898,795
Ibrance	Palbociclib	43	1,197	$675,867
Revlimid	Lenalidomide	32	896	$615,850
Calquence	Acalabrutinib Maleate	45	1,335	$497,895
Cabometyx	Cabozantinib S-Malate	15	450	$364,199

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	N/R	15	$2,569
B4034	Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	14	$1,460
J8521	Capecitabine, oral, 500 mg	N	N/R	46	$1,244
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	12	35	$640
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	19	$238

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	115	$8,290	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	9	$27,997	PFIZER INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Steven Jeffrey Hager, D.O.?

Tedicare shows public-source Medicare data for Steven Jeffrey Hager, D.O. (NPI 1326087917), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Steven Jeffrey Hager, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Steven Jeffrey Hager, D.O.?

Steven Jeffrey Hager, D.O. is linked to CALIFORNIA CANCER ASSOCIATES FOR RESEARCH AND EXCELLENCE INC (billing NPI 1083661607) in the available physician profile data.

Does Steven Jeffrey Hager, D.O. have Open Payments data?

Steven Jeffrey Hager, D.O. has 124 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.